NEW YORK (GenomeWeb News) — Sigma Aldrich yesterday reported flat second-quarter revenue growth as net income grew 12 percent.
 
Total revenues for the three months ended June 30 increased to $449 million from $444 million year over year.
 
Net income grew 12 percent to $70.3 million from $62.5 million year over year, the company said
 
Research and development expenses increased 2 percent to $13.4 million from $13.1 in the prior-year period.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

23andMe's Anne Wojcicki ponders DNA and what it means to be human in a New York Times essay.

A new estimate places the last universal common ancestor to life on Earth as living 3.9 billion years ago, Inverse reports.

In PNAS this week: retinitis pigmentosa gene therapy, role of microbiome in growth stunting, and more.

Bloomberg reports that researchers and drug companies are modeling anti-obesity treatments after the rare genetic condition essential fructosuria.